skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 7,198  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study
Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study
Material Type:
Article 		Add to My Research

Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study

BMC cancer, 2022-02, Vol.22 (1), p.194-194, Article 194 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09303-y ;PMID: 35189858

Full text available

Citations Cited by
2
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Material Type:
Article 		Add to My Research

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

BMC cancer, 2022-01, Vol.22 (1), p.112-112, Article 112 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09226-8 ;PMID: 35086517

Full text available

Citations Cited by
3
Colorectal cancer liver metastases - a population-based study on incidence, management and survival
Colorectal cancer liver metastases - a population-based study on incidence, management and survival
Material Type:
Article 		Add to My Research

Colorectal cancer liver metastases - a population-based study on incidence, management and survival

BMC cancer, 2018-01, Vol.18 (1), p.78-78, Article 78 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3925-x ;PMID: 29334918

Full text available

Citations Cited by
4
Randomised phase II trial of trifluridine/tipiracil
Randomised phase II trial of trifluridine/tipiracil
Material Type:
Article 		Add to My Research

Randomised phase II trial of trifluridine/tipiracil

BMC cancer, 2023-08, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11199-1

Full text available

Citations Cited by
5
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Material Type:
Article 		Add to My Research

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

BMC cancer, 2023-02, Vol.23 (1), p.192-192, Article 192 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10662-3 ;PMID: 36849943

Full text available

Citations Cited by
6
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy
Material Type:
Article 		Add to My Research

Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapy

BMC cancer, 2023-02, Vol.23 (1), p.190-190, Article 190 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10666-z ;PMID: 36849899

Full text available

Citations Cited by
7
C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesis
C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesis
Material Type:
Article 		Add to My Research

C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesis

BMC cancer, 2023-01, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10543-9

Full text available

Citations Cited by
8
The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study
The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study
Material Type:
Article 		Add to My Research

The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study

BMC cancer, 2018-04, Vol.18 (1), p.476-476, Article 476 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-018-4353-2 ;PMID: 29699509

Full text available

Citations Cited by
9
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
Material Type:
Article 		Add to My Research

Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment

BMC cancer, 2022-11, Vol.22 (1), p.1224-1224, Article 1224 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10335-7 ;PMID: 36443715

Full text available

Citations Cited by
10
Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment
Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment
Material Type:
Article 		Add to My Research

Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatment

BMC cancer, 2022-11, Vol.22 (1) [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10320-0

Full text available

Citations Cited by
11
Development and validation of a patient reported experience measure for experimental cancer medicines
Development and validation of a patient reported experience measure for experimental cancer medicines
Material Type:
Article 		Add to My Research

Development and validation of a patient reported experience measure for experimental cancer medicines

BMC cancer, 2024-04, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-11963-x

Full text available

Citations Cited by
12
Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis
Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Correction: The value of oral selective estrogen receptor degraders in patients with HR-positive, HER2-negative advanced breast cancer after progression on ≥ 1 line of endocrine therapy: systematic review and meta-analysis

BMC cancer, 2024-02, Vol.24 (1), p.205-205 [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-11932-4 ;PMID: 38350924

Full text available

Citations Cited by
13
Interaction between Wnt/[beta]-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma
Interaction between Wnt/[beta]-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma
Material Type:
Article 		Add to My Research

Interaction between Wnt/[beta]-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma

BMC cancer, 2024-02, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-11907-5

Full text available

Citations Cited by
14
Protocol for the development of a Core Outcome Set with cancer
Protocol for the development of a Core Outcome Set with cancer
Material Type:
Article 		Add to My Research

Protocol for the development of a Core Outcome Set with cancer

BMC cancer, 2024-01, Vol.24 (1) [Peer Reviewed Journal]

COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11716-2

Full text available

Citations Cited by
15
Promising preclinical patient-derived organoid models in upper gastrointestinal cancers: progress and challenges
Promising preclinical patient-derived organoid models in upper gastrointestinal cancers: progress and challenges
Material Type:
Article 		Add to My Research

Promising preclinical patient-derived organoid models in upper gastrointestinal cancers: progress and challenges

BMC cancer, 2023-12, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11434-9

Full text available

Citations Cited by
16
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority
Material Type:
Article 		Add to My Research

Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority

BMC cancer, 2019-10, Vol.19 (1), p.943-943, Article 943 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6181-4 ;PMID: 31604468

Full text available

Citations Cited by
17
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFR[beta]/NF-κB signaling pathway
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFR[beta]/NF-κB signaling pathway
Material Type:
Article 		Add to My Research

Atovaquone inhibits colorectal cancer metastasis by regulating PDGFR[beta]/NF-κB signaling pathway

BMC cancer, 2023-11, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11585-9

Full text available

Citations Cited by
18
Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary glandï
Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary glandï
Material Type:
Article 		Add to My Research

Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary glandï

BMC cancer, 2023-10, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11466-1

Full text available

Citations Cited by
19
Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small
Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small
Material Type:
Article 		Add to My Research

Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small

BMC cancer, 2023-10, Vol.23 (1) [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11454-5

Full text available

Citations Cited by
20
Population-based phase II trial of stereotactic ablative radiotherapy
Population-based phase II trial of stereotactic ablative radiotherapy
Material Type:
Article 		Add to My Research

Population-based phase II trial of stereotactic ablative radiotherapy

BMC cancer, 2018-10, Vol.18 (1) [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-018-4859-7

Full text available

Citations Cited by

Results 1 - 20 of 7,198  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2009  (192)
  2. 2009 To 2011  (670)
  3. 2012 To 2014  (435)
  4. 2015 To 2018  (2,003)
  5. After 2018  (3,898)
  6. More options open sub menu

Subject 

  1. Oncology  (6,643)
  2. Life Sciences & Biomedicine  (6,609)
  3. Science & Technology  (6,609)
  4. Humans  (5,258)
  5. Cancer  (3,650)
  6. Female  (3,350)
  7. Health Aspects  (3,008)
  8. Analysis  (2,824)
  9. Diagnosis  (2,725)
  10. Patients  (2,513)
  11. Middle Aged  (2,479)
  12. Male  (2,427)
  13. Prognosis  (2,271)
  14. Tumors  (2,222)
  15. Chemotherapy  (2,211)
  16. Cancer Therapies  (2,204)
  17. Aged  (2,147)
  18. Metastasis  (2,138)
  19. Patient Outcomes  (2,002)
  20. More options open sub menu

Language 

  1. Japanese  (842)
  2. French  (1)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait